Global Retirement Partners’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$168 Buy
+20
New +$167 ﹤0.01% 4404
2025
Q4
$309 Hold
25
﹤0.01% 4069
2025
Q3
$221 Sell
25
-4
-14% -$31 ﹤0.01% 3731
2025
Q2
$185 Buy
+29
New +$166 ﹤0.01% 3675
2024
Q4
$277 Hold
29
﹤0.01% 3473
2024
Q3
$242 Hold
29
﹤0.01% 3357
2024
Q2
$198 Buy
29
+20
+222% +$86 ﹤0.01% 3413
2024
Q1
$23 Hold
9
﹤0.01% 3353
2023
Q4
$18 Sell
9
-266
-97% -$625 ﹤0.01% 3330
2023
Q3
$806 Hold
275
﹤0.01% 2821
2023
Q2
$2.02K Hold
275
﹤0.01% 2547
2023
Q1
$2.32K Buy
275
+266
+2,956% +$3.21K ﹤0.01% 2449
2022
Q4
$106 Sell
9
-33
-79% -$511 ﹤0.01% 2968
2022
Q3
$1K Buy
42
+11
+35% +$306 ﹤0.01% 2434
2022
Q2
$1K Sell
31
-2
-6% -$68 ﹤0.01% 2411
2022
Q1
$1K Buy
+33
New +$1.46K ﹤0.01% 2368
2020
Q4
Sell
-55
Closed -$6K 1749
2020
Q3
$6K Buy
+55
New +$5.93K ﹤0.01% 1274

Other funds holding EBS

Global Retirement Partners's EBS Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Emergent Biosolutions (EBS) in Q2 2026: 20 shares worth $168. The stake represents ﹤0.01% of the portfolio and ranks #4404 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in EBS as recently as Q4 2025.

Global Retirement Partners first reported a position in EBS in Q3 2020 and has held it in 17 quarters since. The position peaked at $6K in Q3 2020. 194 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Global Retirement Partners held 20 shares of Emergent Biosolutions worth $168 as of Q2 2026.
  • Emergent Biosolutions was a new Global Retirement Partners position in Q2 2026.
  • Emergent Biosolutions made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #4404 holding.
  • Global Retirement Partners first reported a position in Emergent Biosolutions in Q3 2020 and has held it in 17 quarters since.
  • Global Retirement Partners's Emergent Biosolutions position peaked at $6K in Q3 2020.
  • 194 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.